OSR Health

An Open and Socially Responsible Healthcare Group / [email protected]

[OSR Health @OSRHealth]

$OSRH

https://t.co/Blp7OINUg0

[OSR Health @OSRHealth]

$OSRH

https://t.co/fpFe2KykLw

[OSR Health @OSRHealth]

$OSRH

https://t.co/1rPtk0p8ER

[KIR @KeepRealistic]

$OSRH $15 million in funding at a very high premium (in 4 Tranches)

https://t.co/WUmHTqsH42

[OSR Health @OSRHealth]

$OSRH CVR Enrollment is officially closed.

Thank you to all who enrolled in this unique program to reward shareholder loyalty.

We’ll contact each shareholder individually over the coming days to confirm final enrollment.

Thank you for your continued support of OSR Health!

[OSR Health @OSRHealth]

$OSRH

Shareholder Loyalty CVR Program: enrollment remains open until September 13.

Please complete the process before then.

Submit here: https://t.co/nd4tJIWKXr

Thanks to all who have submitted so far, we'll come back to you to confirm your enrollment in due course.

[OSR Health @OSRHealth]

$OSRH Shareholder Loyalty CVR Program

Thank you to all who have enrolled so far.

The Enrollment Window remains open until September 13. Two weeks left!

So for holders as of Record Date August 14, still time to enroll for rewards.

https://t.co/nd4tJIWKXr

[OSR Health @OSRHealth]

$OSRH

https://t.co/htdGwIAsLr

[OSR Health @OSRHealth]

$OSRH

https://t.co/HDfWQFHGf6

[OSR Health @OSRHealth]

$OSRH

https://t.co/Z4mA847MXn

[OSR Health @OSRHealth]

$OSRH

Today is Record Date for the Shareholder Loyalty CVR Program!

- Hold as of today, the Record Date
- Enroll your shares
- Hold continuously for 12 months
- Potentially receive extra shares as milestones are met
https://t.co/nd4tJIWKXr

*CVR delivery subject to conditions

[OSR Health @OSRHealth]

$OSRH

3 Days to Record Date!

Shareholder Loyalty CVR Program:
- Record Date August 14
- Hold and Enroll to qualify
- Recieve extra shares as milestones are met

Details:
https://t.co/nd4tJIWKXr

[OSR Health @OSRHealth]

$OSRH

An important takeaway from today’s CEO letter:

Two OSR subsidiaries have received inbound out-licensing interest.

https://t.co/5lGK9gU1Rs

We aim to translate this external validation of our technologies and IP into long-term shareholder value.

[OSR Health @OSRHealth]

$OSRH

https://t.co/5lGK9gU1Rs

[OSR Health @OSRHealth]

$OSRH Shareholder Loyalty CVR Program

One week until Record Date!

Following shareholder approval our AGM today, $OSRH has the share capacity to support the extra shares to reward our enrolled shareholders.

Hold and enroll to be eligible:
https://t.co/nd4tJIWKXr

[OSR Health @OSRHealth]

Thank you, $OSRH shareholders.

Our 2026 AGM was held today, with all proposals presented approved.

This support helps us to keep moving our platforms forward:
Vaximm's oral immunotherapies
Woori IO's non-invasive glucose montoring
Darnatein's regenerative medicine

Onward!

[OSR Health @OSRHealth]

Public companies want you to buy and hold.

$OSRH wants to reward you for it.

The Shareholder Loyalty CVR Program is built to reward the shareholders who stick with us as milestones are met.

Record Date: August 14.

How it works: https://t.co/nd4tJIWd7T

[OSR Health @OSRHealth]

Only 8 trading days until Record Date.

Prepare now!

$OSRH

[OSR Health @OSRHealth]

$OSRH Shareholder Loyalty CVR Program

A tiered program that rewards shareholders with additional shares as milestones are met

A unique way to reward conviction shareholders

Record Date August 14

Hold and Enroll to qualify

More details:
https://t.co/nd4tJIWd7T

[ACCESS Newswire @AccesswireNews]

$OSRH Vaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its ... https://t.co/f7a95UB0cg

[The Biotech Newswire @BiotechNewswire]

#Vaximm AG, an #OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform https://t.co/6S3rn39kQk #biotech #oncology #immunotherapy @immunotherapy @sitcancer